Stockreport

Assessing Arcutis Biotherapeutics After 99% YTD Surge and Mixed Valuation Signals [Yahoo! Finance]

Arcutis Biotherapeutics, Inc. - Common stock  (ARQT) 
PDF The stock has been volatile lately, slipping about 7.0% over the last week, but it is still up 16.1% over 30 days, 99.3% year to date and 128.7% over the past year, whi [Read more]